Deparment of Immunology
Moffitt Cancer Center
United States of America
Dr. Jianguo Tao is affiliated to Deparment of Immunology, Moffitt Cancer Center. Dr. Jianguo Tao is currently providing services as Researcher. Dr. Jianguo Tao has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Jianguo Tao contributions have acclaimed recognition from honourable subject experts around the world. Dr. Jianguo Tao is actively associated with different societies and academies. Dr. Jianguo Tao academic career is decorated with several reputed awards and funding. Dr. Jianguo Tao research interests include identifying major molecular determinants for drug response and resistance, as well as novel targets for overcoming or preventing drug resistance evolution in mantle cell lymphoma and double hit lymphoma (DHL).
Identifying major molecular determinants for drug response and resistance, as well as novel targets for overcoming or preventing drug resistance evolution in mantle cell lymphoma and double hit lymphoma (DHL)
Shain KH, Dalton WS, Tao J. The tumor microenvironment shapes hallmarks of mature B-cell malignancies. Oncogene. 2015 Sep;34(36):4673-4682.
Srikumar T, Markow M, Centeno B, Hoffe S, Tao J, Fernandez H, Strosberg J, Shibata D. Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma. Curr Oncol. 2016 Feb;23(1):e70-e74.
Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads MB, Jacobson T, Silva M, Distler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski LC, Koomen JM, Dalton WS, Shain KH, Wang M, Sotomayor E, Tao J. Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma. Nat Commun. 2017 Apr;8:14920.